In terms of detailed inhibitory receptor expression analysis, significantly higher fractions of tumor-infiltrated CD4+ T cells expressed LAG-3 (13.06 ± 4.63% of CD4+ T cells) and PD-1 (14.01 ± 3.76% of CD4+ T cells, Figure 5A). The gene discussed is CD4; the disease is neoplasm.